Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
The Henry J. Kaiser Family Foundation

Growing Global Vaccine Market Helping Spur Drug Companies To Pursue Ebola Vaccine

The New Yorker: The Race for an Ebola Vaccine “…So why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson — three of the world’s biggest drug manufacturers? … [O]ver the past several years, companies have realized that the difficulties of making vaccines could be…

News Summary Read More
The Henry J. Kaiser Family Foundation

Merck Purchasing Rights To NewLink’s Experimental Ebola Vaccine

News outlets report on a deal between pharmaceutical companies Merck and NewLink to develop, test, and market a potential Ebola vaccine. NPR: Merck Partners With NewLink To Speed Up Work On Ebola Vaccine “[Monday] NewLink Genetics said it has made a deal with drugmaker Merck to research, develop, manufacture, and…

News Summary Read More
The Henry J. Kaiser Family Foundation

Gates Foundation To Require Open Access To Journal Articles On Research It Funds

Vox: The Gates Foundation pushes to make more academic research free and open to the public “Starting in January 2017, the Bill & Melinda Gates Foundation will require all of the researchers it funds to be published in a manner that is free for the public to read, according to…

News Summary Read More
The Henry J. Kaiser Family Foundation

Blog Post Recognizes 10 Global Health Advancements

Global Health Technologies Coalition’s “Breakthroughs”: Ten global health advancements I’m thankful for this Thanksgiving Marissa Chmiola, GHTC’s communications officer, discusses 10 global health advancements, including progress in vaccine research for hookworm and dengue, development of women-specific HIV prevention methods, and formulations of pediatric tuberculosis treatments, as well as other topics…

News Summary Read More
The Henry J. Kaiser Family Foundation

Increased Funding For NIH Infectious Diseases Research ‘An Investment In Our Health And Our Future’

Seattle Times: Fund the National Institutes of Health to fight infectious diseases Alan Aderem, president and director of Seattle BioMed “…Disease research is some of the most critical and challenging work of the 21st century. Increased funding to the NIH is the single most important component to discovering new vaccines,…

News Summary Read More
The Henry J. Kaiser Family Foundation

Ebola Treatments Would Qualify For FDA Priority Review Under Bill Passed By Senate Committee

The Hill: Senate panel passes measure to speed up approval of Ebola drugs “The Senate Health, Education, Labor and Pensions (HELP) Committee approved a measure Wednesday designed to speed the approval of Ebola drugs. The bill (S 2917) would make Ebola treatments eligible for priority review vouchers at the Food…

News Summary Read More
The Henry J. Kaiser Family Foundation

Gilead Purchases FDA Priority Review Voucher For $125M

NPR: Gilead Buys Shortcut For FDA Drug Review For $125 Million “…In an auction, Gilead Sciences, a maker of HIV and hepatitis medicines, just bought a coupon good for the accelerated review of a drug of the company’s choice from Knight Therapeutics, a Canadian company. The priority review voucher entitles…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. Should Improve Hospital Preparedness For Ebola, Create PPPs To Spur Treatment, Vaccine Development

Roll Call: Fighting Ebola Requires Better Planning Sens. Edward Markey (D-Mass.) and Rob Portman (R-Ohio) “…[W]hile it is clear the U.S. health care system ultimately rose to the challenge of caring for multiple Ebola patients, the grave mistakes made in Texas should serve as a wake-up call. We must ensure…

News Summary Read More
The Henry J. Kaiser Family Foundation

WHO Initiatives Aim To Stimulate Innovation In Effort To Develop Rapid Ebola Tests

Media sources report on the WHO’s launch of two initiatives that aim to develop more rapid and safe Ebola diagnostic tests, which the agency says are urgently needed in West Africa. Reuters: WHO seeks swifter Ebola test to help stamp out epidemic “The World Health Organization is seeking faster and cheaper tests…

News Summary Read More
The Henry J. Kaiser Family Foundation

Gates Foundation Pledges $5.7M Toward Ebola Treatment Trials

News outlets report on the Bill & Melinda Gates Foundation’s pledge of $5.7 million to test experimental Ebola treatments in West Africa. BBC News: Ebola outbreak: $5.7m pledged for blood plasma trials “The Bill & Melinda Gates Foundation has pledged $5.7m towards a program to increase production of experimental Ebola…

News Summary Read More